Low-dose Atropine for the Prevention of Myopia Progression in Danish Children

The main hypotheses tested in this study are: ‐ 0.01% atropine one drop nightly reduces the progression of childhood myopia in Danish children. ‐ 0.01% atropine one drop nightly is safe and with no significant side effects. ‐ A 6‐month loading dose of 0.1% atropine followed by a 0.01% atropine maintenance dose is superior to single 0.01% atropine. ‐ 0.1% atropine one drop nightly is safe and has tolerable side effects. ‐ The rebound effect after stopping both atropine regimens is limited. ‐ Choroidal thickness is a predictor for the progression of childhood myopia.